Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Michael Lanosa |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents / Megan Ehret en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 10 (Octubre)
[artículo]
Título : The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents : a meta analysis Tipo de documento: texto impreso Autores: Megan Ehret, Autor ; John W. Goethe, Autor ; Michael Lanosa, Autor Fecha de publicación: 2022 Artículo en la página: pp. 1286-1292 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antropometría, Antipsicóticos, Índice de masa corporal, Diabetes Mellitus Tipo 2, Metformina. Resumen: In the Clinical Antipsychotic Trials of Intervention Effectiveness, atypical antipsychotics (AAPs) were found to be associated with weight gain and impairment of glucose metabolism. While metformin has been shown to attenuate weight gain and insulin resistance, not all studies have shown a benefit in the reduction of antipsychotic-induced weight gain and insulin resistance. Link: ./index.php?lvl=notice_display&id=28238
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 10 (Octubre) . - pp. 1286-1292[artículo] The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents : a meta analysis [texto impreso] / Megan Ehret, Autor ; John W. Goethe, Autor ; Michael Lanosa, Autor . - 2022 . - pp. 1286-1292.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 10 (Octubre) . - pp. 1286-1292
Palabras clave: Antropometría, Antipsicóticos, Índice de masa corporal, Diabetes Mellitus Tipo 2, Metformina. Resumen: In the Clinical Antipsychotic Trials of Intervention Effectiveness, atypical antipsychotics (AAPs) were found to be associated with weight gain and impairment of glucose metabolism. While metformin has been shown to attenuate weight gain and insulin resistance, not all studies have shown a benefit in the reduction of antipsychotic-induced weight gain and insulin resistance. Link: ./index.php?lvl=notice_display&id=28238